TD Cowen Maintains Hold on BioNTech, Raises Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Werber maintains a Hold rating on BioNTech (NASDAQ:BNTX) and raises the price target from $95 to $98.
May 07, 2024 | 4:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen analyst Yaron Werber maintains a Hold rating on BioNTech and raises the price target from $95 to $98.
The increase in price target by TD Cowen suggests a positive outlook on BioNTech's future performance, potentially leading to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100